Company Overview and News

0
Freehold Royalties Ltd. Declares Dividend for July 2018

2018-07-12 globenewswire
CALGARY, Alberta, July 12, 2018 (GLOBE NEWSWIRE) -- Freehold Royalties Ltd. (Freehold) (TSX:FRU) announces that its Board of Directors has declared a dividend of Cdn. $0.0525 per common share to be paid on August 15, 2018 to shareholders of record on July 31, 2018.
FRU FRHLF

10
This Little Known Oil Stock Has Outperformed The Dividend Aristrocrats

2018-06-29 seekingalpha
Using very little debt Freehold has outperformed most large cap oil stocks even without having downstream operations that some of its large cap brethren have.
FRU BOE XOM DVN FRHLF

0
Freehold Royalties Ltd. Declares Dividend for June 2018

2018-06-12 globenewswire
CALGARY, Alberta, June 12, 2018 (GLOBE NEWSWIRE) -- Freehold Royalties Ltd. (Freehold) (TSX:FRU) announces that its Board of Directors has declared a dividend of Cdn. $0.0525 per common share to be paid on July 16, 2018 to shareholders of record on June 30, 2018.
FRU FRHLF

0
Freehold Royalties' (FRHLF) CEO Tom Mullane on Q1 2018 Results - Earnings Call Transcript

2018-05-13 seekingalpha
Please be advised that certain statements on this call constitute forward-looking information. These statements relate to future events or our expectations for future performance. All statements, other than those of historical facts, may be forward-looking and we caution the listener.
FRU FRHLF

0
Freehold Royalties Ltd. Shareholders Approve Resolutions at Annual Meeting

2018-05-10 globenewswire
CALGARY, Alberta, May 09, 2018 (GLOBE NEWSWIRE) -- Freehold Royalties Ltd. (Freehold) (TSX:FRU) announced today that all nominees listed in its notice of meeting and information circular dated March 23, 2018, were elected as directors of Freehold at its Annual Meeting of Shareholders held today in Calgary.
FRU FRHLF

0
Freehold Royalties Ltd. Announces Continued Royalty Growth and First Quarter Results

2018-05-09 globenewswire
CALGARY, Alberta, May 09, 2018 (GLOBE NEWSWIRE) -- Freehold Royalties Ltd. (Freehold) (TSX:FRU) announced first quarter results for the period ended March 31, 2018.
FRU FRHLF

0
Freehold Royalties Ltd. Declares Dividend for April 2018

2018-04-11 globenewswire
CALGARY, Alberta, April 11, 2018 (GLOBE NEWSWIRE) -- Freehold Royalties Ltd. (Freehold) (TSX:FRU) announces that its Board of Directors has declared a dividend of Cdn. $0.0525 per common share to be paid on May 15, 2018 to shareholders of record on April 30, 2018.
FRU FRHLF

0
Freehold Royalties Ltd. Announces Investor Day Event

2018-04-09 globenewswire
CALGARY, Alberta, April 09, 2018 (GLOBE NEWSWIRE) -- Freehold Royalties Ltd. (Freehold) (TSX:FRU) announces it will hold its Investor Day in Toronto today beginning at 3:00pm EST. The event will include a formal presentation by Freehold's management and technical teams, showcasing Freehold's 2017 Asset Book.
FRU FRHLF

0
Freehold Royalties Ltd 2017 Q4 - Results - Earnings Call Slides

2018-03-12 seekingalpha
The following slide deck was published by Freehold Royalties Ltd in conjunction with their 2017 Q4 earnings call.
FRU FRHLF

Related Articles

CYTX: Cytori Therapeutics Analysis and Research Report

6h - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CATB: Catabasis Pharmaceuticals Analysis and Research Report

2018-07-13 - Asif

Overview Catabasis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics based on its proprietary Safely Metabolized And Rationally Targeted linker, or SMART LinkerSM, drug discovery platform. The company's SMART Linker drug discovery platform enables it to engineer product candidates that can simultaneously modulate multiple targets in a disease. The company's proprietary product candidates impact pathways that are central to diseases where efficacy may be optimized by a multiple target approach. Catabasis Pharmaceuticals has applied its SMART Linker drug discovery platform to build an internal pipeline of product candidates for rare diseases, its primary focus, and plan to pursue partnerships to develop additional product candidates. The company's lead product candidate is edasalonexent, formerly known as CAT-1004, which the company believe has the potential to be a disease-modifying...

WMT: Walmart Analysis and Research Report

2018-07-09 - Asif

Overview Walmart Inc. helps people around the world save money and live better – anytime and anywhere – in retail stores and through eCommerce. Through innovation, Walmart is striving to create a customer-centric experience that seamlessly integrates its eCommerce and retail stores in an omni-channel offering that saves time for its customers. Each week, the company serve nearly 270 million customers who visit its more than 11,700 stores and numerous eCommerce websites under 65 banners in 28 countries. The company's strategy is to lead on price, invest to differentiate on access, be competitive on assortment and deliver a great experience. Leading on price is designed to earn the trust of its customers every day by providing a broad assortment of quality merchandise and services at everyday low prices ("EDLP"). EDLP is its pricing philosophy under which the company price items at a low price every day so its customers trust that its prices will not change under frequent prom...

CUSIP: 356500108